Co-labeling of LHX4 and VSX2, a pan-BC marker (Jung et al., 2015), showed that all LHX4+ cells were VSX2+ BCs and 39.8% of VSX2+ BCs were LHX4+ cells (Figures 1A, S1A, and S1B). Here, LHX4 is linked to breast cancer.